Wesener MC, Demel UM, Pabst T, Teipel R, Albici A-M, von Tresckow B, Teichert M, Boquoi A, Holderried T, Schmitz F, Müller F, Rößiger F-L, Hoffmann M, Schub N, Tovar N, Oliver-Caldes A, Kröger N, Baermann B-N, Bohl S, Fandrei D, Vucinic V, Strassl I, Stölzel F, de Larrea CF, Keller U, Busse A, Merz M, Gagelmann N. Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma. Haematologica; https://doi.org/10.3324/haematol.2026.301082 [Early view].